AKEBIA THERAPEUTICS INC's ticker is AKBA and the CUSIP is 00972D105. A total of 155 filers reported holding AKEBIA THERAPEUTICS INC in Q1 2018. The put-call ratio across all filers is 0.03 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $84,000 | -84.9% | 17,353 | -70.3% | 0.01% | -77.3% |
| Q1 2018 | $556,000 | +70.0% | 58,371 | +156.4% | 0.02% | +29.4% |
| Q2 2017 | $327,000 | +247.9% | 22,770 | +121.7% | 0.02% | +325.0% |
| Q1 2017 | $94,000 | -74.2% | 10,270 | -71.0% | 0.00% | -66.7% |
| Q2 2015 | $364,000 | +93.6% | 35,375 | +108.1% | 0.01% | +100.0% |
| Q1 2015 | $188,000 | +58.0% | 17,002 | +65.2% | 0.01% | +50.0% |
| Q4 2014 | $119,000 | -53.5% | 10,290 | +11.3% | 0.00% | -69.2% |
| Q2 2014 | $256,000 | – | 9,246 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 7,031,283 | $95,485,000 | 5.72% |
| GREAT POINT PARTNERS LLC | 3,510,073 | $47,667,000 | 3.81% |
| Logos Global Management LP | 1,200,000 | $16,296,000 | 3.26% |
| DAFNA Capital Management LLC | 762,666 | $10,357,000 | 2.99% |
| Baupost Group | 15,000,000 | $203,700,000 | 2.54% |
| Nantahala Capital Management | 6,101,111 | $82,853,000 | 2.50% |
| Abrams Capital Management | 5,656,462 | $76,815,000 | 2.48% |
| Novo Holdings A/S | 1,987,506 | $26,990,000 | 1.74% |
| Stanley-Laman Group, Ltd. | 316,933 | $4,304,000 | 1.04% |
| Integral Health Asset Management, LLC | 250,000 | $3,395,000 | 1.02% |